Business
Pharmaceutical company Pfizer asks US regulators to allow emergency use of its experimental COVID-19 vaccine – ABC News
Pharmaceutical company Pfizer formally asks US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited…
Pharmaceutical company Pfizer has formally asked US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month.
Key points:
- How much vaccine is available and when is a moving target, but initial supplies will be scarce
- Globally, Pfizer has estimated it could have 50 million doses available by year’s end
- The US Government has a contract to buy millions of Pfizer-BioNTech doses
The action comes days after Pfizer…
Continue Reading
-
Business21 hours ago1 Australian stock you’ll probably kick yourself for not owning a decade from now
-
General17 hours agoLiberals go back to basics after crawling to year’s end
-
Business22 hours ago3 of the best ASX ETFs to build significant wealth
-
General19 hours agoWho’s thriving and who’s barely surviving in Australia, the Land of the Parrots?